Old Web
English
Sign In
Acemap
>
authorDetail
>
Azusa Hoshino-Yoshino
Azusa Hoshino-Yoshino
Chugai Pharmaceutical Co.
Nilotinib
Erlotinib
PK/PD models
Pharmacodynamics
Pharmacology
2
Papers
26
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
In vitro metabolism of alectinib, a novel highly potent alk inhibitor: Contribution of CYP3A enzymes in microsomes and hepatocytes
2017
Drug Metabolism and Pharmacokinetics
Toshito Nakagawa
Kenji Takanashi
Azusa Hoshino-Yoshino
Tsuyoshi Yamauchi
Kosuke Kawashima
Yukako Tachibana
Miyuki Yoshida
Stephen Fowler
Kuresh Youdim
Li Yu
Masaki Ishigai
Show All
Source
Cite
Save
Citations (4)
Bridging from Preclinical to Clinical Studies for Tyrosine Kinase Inhibitors Based on Pharmacokinetics/Pharmacodynamics and Toxicokinetics/Toxicodynamics
2011
Drug Metabolism and Pharmacokinetics
Azusa Hoshino-Yoshino
Motohiro Kato
Kohnosuke Nakano
Masaki Ishigai
Toshiyuki Kudo
Kiyomi Ito
Show All
Source
Cite
Save
Citations (22)
1